Concurrent Chemoradiotherapy with Vinorelbine plus Split-Dose Cisplatin may be an Option in Inoperable Stage III Non-Small Cell Lung Cancer: A Single-Center Experience

BACKGROUND: Concurrent chemoradiotherapy is the current standard treatment for inoperable stage III non-small cell lung cancer (NSCLC). In this study we aimed to investigate the efficacy and toxicity of CCRT with split dose of cisplatin (30 mg/m(2)) and vinorelbine (20 mg/m(2)) in patients with inop...

Descripción completa

Detalles Bibliográficos
Autores principales: Mertsoylu, Hüseyin, Köse, Fatih, Sümbül, Ahmet Taner, Sedef, Ali Murat, Doğan, Özlem, Besen, Ali Ayberk, Parlak, Cem, Fındıkçıoğlu, Alper, Muallaoğlu, Sadık, Sezer, Ahmet, Sakallı, Hakan, Özyılkan, Özgür
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356262/
https://www.ncbi.nlm.nih.gov/pubmed/25731741
http://dx.doi.org/10.12659/MSM.892730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356262/
https://www.ncbi.nlm.nih.gov/pubmed/25731741
http://dx.doi.org/10.12659/MSM.892730

Ejemplares similares